Home/Filings/4/0001140361-16-048511
4//SEC Filing

CytomX Therapeutics, Inc. 4

Accession 0001140361-16-048511

$CTMXCIK 0001501989operating

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 8:45 AM ET

Size

5.5 KB

Accession

0001140361-16-048511

Insider Transaction Report

Form 4
Period: 2016-01-21
Kavanaugh William Michael
CSO, Head Res.&Non-Clin. Dev.
Transactions
  • Award

    Employee Stock Option (right to buy)

    2016-01-21+80,00080,000 total
    Exercise: $14.46Exp: 2026-01-20Common Stock (80,000 underlying)
Footnotes (1)
  • [F1]This option vests in 48 substantially equal monthly installments starting on January 1, 2016.

Documents

1 file

Issuer

CytomX Therapeutics, Inc.

CIK 0001501989

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001501989

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 8:45 AM ET
Size
5.5 KB